MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Organization & Developments (Academia): Research Centers
Organization & Developments (Academia): Harvard
Harvard University Office of Technology Development:Technology Transfer (T2) Candidates:345 (2010)
Attachments
Harvard University Office of Technology Development
Parents
Organization & Developments (Academia): Harvard
Pioneers: iBridge Network (Organizations)
Children
2010: Development of broad spectrum antibiotics for new targets-Harvard University Office of Technology Development
2010: Increasing neural regeneration following traumatic injury-Harvard University Office of Technology Development
2025: Novel candidates for Tuberculosis therapy-Harvard University Office of Technology Development
A biomarker with significant prognostic potential in cancer and neuronal differentiation-Harvard University Office of Technology Development
A novel source of neural stem cells-Harvard University Office of Technology Development
A real-time molecular diagnostic device-Harvard University Office of Technology Development
Algorithm for haplotype construction of single nucleotide polymorphism-Harvard University Office of Technology Development
Antibody purification-Harvard University Office of Technology Development
Cellular basis of vascular-graft stenosis-Harvard University Office of Technology Development
Combination cancer therapies to circumvent induced resistance pathways-Harvard University Office of Technology Development
Database for tracking technology transfer operations-Harvard University Office of Technology Development
Diagnostic test for Alzheimer's disease-Harvard University Office of Technology Development
DNA nanotube liquid crystals for NMR structure determination-Harvard University Office of Technology Development
Dramatic enhancement of transplant organ viability and storage time-Harvard University Office of Technology Development
Drug candidate for neurological stroke and septic shock-Harvard University Office of Technology Development
Endowment angiogenesis-related patents-Harvard University Office of Technology Development
Engineered cardiac tissue with mature electrophysiological properties-Harvard University Office of Technology Development
Home-based nocturnal monitor of cardiac events in high-risk heart disease patients and severe sleep apnea sufferers-Harvard University Office of Technology Development
Improved sensitivity for near-field scanning optical microscopy-Harvard University Office of Technology Development
In vivo evolution of an RNA-based transcriptional activator-Harvard University Office of Technology Development
Label-free in-situ medical imaging-Harvard University Office of Technology Development
Lead compounds for the treatment of pain-Harvard University Office of Technology Development
Localized bioprobes for electrophysiology-Harvard University Office of Technology Development
Low-power, high-speed transducer detects forces at the nano-scale-Harvard University Office of Technology Development
Method of identifying compounds useful for treating autoimmune diseases-Harvard University Office of Technology Development
Methods for treating arteriosclerosis-Harvard University Office of Technology Development
Methods of detecting and treating arterial inflammatory disease-Harvard University Office of Technology Development
MicroArray spot LINEar regression (MASLINER) software-Harvard University Office of Technology Development
New cell sorting technology could replace fluorescent and magnetic technologies-Harvard University Office of Technology Development
New synthetic bone material could improve bone graft surgery-Harvard University Office of Technology Development
New therapeutic targets for the treatment of asthma and COPD-Harvard University Office of Technology Development
Next generation diagnostics for breast cancer, prostate cancer and melanoma-Harvard University Office of Technology Development
Next generation therapeutics for macular degeneration and cancer-Harvard University Office of Technology Development
Novel lipid hormone for identifying and treating metabolic disease-Harvard University Office of Technology Development
Novel lipid hormone for identifying and treating metabolic disease-Harvard University Office of Technology Development
Novel pain therapeutics to improve tolerance and activity-Harvard University Office of Technology Development
Novel peptide therapeutic for multiple sclerosis-Harvard University Office of Technology Development
Novel target for Angelman Syndrome and Autism Spectrum Disorders-Harvard University Office of Technology Development
Novel way of brain mapping to be used in pre-surgical planning-Harvard University Office of Technology Development
Osteoinductive peptides to enhance bone regeneration-Harvard University Office of Technology Development
Portable and inexpensive chemical and biological sensors-Harvard University Office of Technology Development
Production of digitized stereoscopic polarizing images by inkjet printing-Harvard University Office of Technology Development
Receptor-ligand assay for orphan tyrosine kinase receptors-Harvard University Office of Technology Development
Secreted target for type 2 diabetes and metabolic disease-Harvard University Office of Technology Development
Seeing previously invisible molecules for the first time-Harvard University Office of Technology Development
SIRT3 activators for cancer metabolism and SIRT3 inhibitors for vascular disease-Harvard University Office of Technology Development
Small molecule inhibitors of Dengue virus entry-Harvard University Office of Technology Development
Small molecule therapeutic for drugs against chronic neural degenerative diseases-Harvard University Office of Technology Development
Software for early detection and assessment of depression-Harvard University Office of Technology Development
System and algorithms for disease prediction-Harvard University Office of Technology Development
System and method for providing high-detail, low-cost 3D lung imaging-Harvard University Office of Technology Development
Target protectors of miRNA-Harvard University Office of Technology Development
Wogonin Wogonin - a drug candidate for pain and epilepsy